Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference


Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that its Chairman and Chief Executive Officer, Rodney Varner, is scheduled to present at the 4th Annual Disruptive Growth Conference hosted by ReedSmith in New York City on September 4, 2019.

Genprex will present at the 4th Annual Disruptive Growth Conference as follows:

Date: Wednesday, September 4, 2019

Time: 5:00-5:15 p.m. EDT

Venue: ReedSmith Offices, 599 Lexington Avenue, 22nd Floor, New York City

Room: Presentation Room A/B

The 2019 Disruptive Growth Conference will offer the exclusive opportunity to discover growth companies with disruptive technologies and business models covering the following sectors: communications, consumer, energy/alternative energy, healthcare, industrial, life sciences, natural resources and technology.

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex's initial product candidate, Oncoprextm immunogene therapy for non-small cell lung cancer (NSCLC). Genprex's platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company's web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc, and LinkedIn at linkedin.com/company/genprex.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the effects of Oncoprex on cancer. Risks and uncertainties associated with Genprex and its lead product candidate Oncoprex are described more fully under the caption "Risk Factors" and elsewhere in our filings and reports with the United States Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


These press releases may also interest you

at 03:05
Attentive, the AI marketing platform for leading brands, has seen 128% revenue growth in the UK over the last year and has doubled the size of its UK team. The company's momentum underscores the market's continued demand for personalised SMS...

at 03:01
ComplyAdvantage, a leader in financial crime intelligence, today announced its acquisition of Golden (Golden Recursion Inc). Golden is a San Francisco-based innovator automating the construction of one of the world's largest knowledge...

at 03:00
Guidewire launched its first-ever DEVSummit, a two-day event designed to unite, educate, and energize the global Guidewire development community. At DEVSummit 2024, attendees will hear mainstage keynote presentations from Guidewire industry and...

at 03:00
What is new in JobPts - Culture & Recognition? We're committed to providing organizations with the most engaging and secure recognition programs available. These new...

at 03:00
GameChange Solar, a leading global supplier of solar tracking solutions for ground-mounted PV plants, has been selected to supply its Genius Trackertm solar trackers for four new solar projects totalling over 500 megawatts (MW) in Southern Africa....

at 03:00
Clarivate Plc , a leading global provider of transformative intelligence, today announces it has signed the United Nations Sustainable Development Goals (UN SDGs) Publishers Compact. Signatories of the compact pledge to develop sustainable practices...



News published on and distributed by: